Thrombolytic therapy for deep venous thrombosis?

JAMA

Volumn 282, Issue 22, 1999, Pages 2164-2166

  Horne III, McDonald K ^a,b   Chang, Richard ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

ADULT; ARTICLE; CASE REPORT; CAVA VEIN OBSTRUCTION; COLON CANCER; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; FIBRINOLYTIC THERAPY; HEPARINIZATION; HUMAN; LIVER METASTASIS; MALE; PHLEBOGRAPHY; PRIORITY JOURNAL;

EID: 0033537008     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.282.22.2164     Document Type: Article

References (26)

1. Thrombolytic therapy in thrombosis: a National Institutes of Health consensus development conference. Ann Intern Med. 1980;93:141-144.
2. Schulman S, Rhedin A-S, Lindmarker P, et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. N Engl J Med. 1995;332:1661-1665.
3. Comerota AJ. Thrombolytic therapy for acute deep vein thrombosis. In: Comerota AJ, ed. Thrombolytic Therapy for Peripheral Vascular Disease. Philadelphia, Pa: JB Lippincott Co; 1995:175-195.
4. Mewissen MW, Seabrook GR, Meissner MH, Cynamon J, Labropoulos N, Haughton SH. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology. 1999;211:39-49.
5. 1998 Drug Topics Red Book. Montvale, NJ: Medical Economics Books; 1998.
6. Levine M, Gent M, Hirsh J, et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med. 1996;334:677-681.
7. Schafer AI. Venous thrombosis as a chronic disease. N Engl J Med. 1999;340:955-956.
8. Prandoni P, Lensing AWA, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996;125:1-7.
9. Killewich LA, Martin R, Cramer M, Beach KW, Strandness DE. An objective assessment of the physiologic changes in the postthrombotic syndrome. Arch Surg. 1985;120:424-426.
10. Akesson H, Brudin L, Dahlstrom JA, Eklof B, Ohlin P, Plate G. Venous function assessed during a 5-year period after acute iliofemoral venous thrombosis treated with anticoagulation. Eur J Vasc Surg. 1990;4:43-48.
11. Schulman S, Granqvist S, Holmstrom M, et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. N Engl J Med. 1997;336:393-398.
12. Watz R, Savidge GF. Rapid thrombolysis and preservation of valvular venous function in high deep vein thrombosis. Acta Med Scand. 1979;205:293-298.
13. Killewich LA, Bedford GR, Beach KW, Strandness DE. Spontaneous lysis of deep venous thrombi: rate and outcome. J Vasc Surg. 1989;9:89-97.
14. Meissner MH, Manzo RA, Bergelin RO, Markel A, Strandness DE. Deep venous insufficiency: the relationship between lysis and subsequent reflux. J Vasc Surg. 1993;18:596-608.
15. Holmstrom M, Lindmarker P, Granqvist S, Johnsson H, Lockner D. A 6-month venographic follow-up in 164 patients with acute deep vein thrombosis. Thromb Haemost. 1997;78:803-807.
16. Elliot MS, Immelman EJ, Jeffery P, et al. A comparative randomized trial of heparin versus streptokinase in the treatment of acute proximal venous thrombosis: an interim report of a prospective trial. Br J Surg. 1979;66:838-843.
17. Arnesen H, Hoiseth A, Ly B. Streptokinase or heparin in the treatment of deep vein thrombosis. Acta Med Scand. 1982;211:65-68.
18. Tarry WC, Makhoul RG, Tisnado J, Posner MP, Sobel M, Lee HM. Catheter-directed thrombolysis following vena cava filtration for severe deep venous thrombosis. Ann Vasc Surg. 1994;8:583-590.
19. Patel NH, Plorde JJ, Meissner M. Catheter-directed thrombolysis in the treatment of phlegmasia cerulea dolens. Ann Vasc Surg. 1998;12:471-475.
20. Centeno RF, Nguyen AH, Ketterer C, Stiller G, Chait A, Fallahnejad M. An alternative approach: antegrade catheter-directed thrombolysis in a case of phlegmasia cerulea dolens. Am Surg. 1999;65:229-231.
21. Brown WD, Goldhaber SZ. How to select patients with deep vein thrombosis for tPA therapy. Chest. 1989;95(suppl):276S-278S.
22. Research Committee of the British Thoracic Society. Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism. Lancet. 1992;340:873-876.
23. Rogers LQ, Lutcher CL. Streptokinase therapy for deep vein thrombosis: a comprehensive review of the English literature. Am J Med. 1990;88:389-395.
24. Markel A, Manzo RA, Strandness DE. The potential role of thrombolytic therapy in venous thrombosis. Arch Intern Med. 1992;152:1265-1267.
25. O'Meara JJ, McNutt RA, Evans AT, Moore SW, Downs SM. A decision analysis of streptokinase plus heparin as compared with heparin alone for deep-vein thrombosis. N Engl J Med. 1994;330:1864-1869.
26. Collen D, Lijnen HR. Tissue-type plasminogeri activator: mechanism of action and thrombolytic properties. Haemostasis. 1986;16(suppl 3):25-32.